Health & Pharma

Endo’s end around: How a huge Philadelphia-based opioid maker escaped a $7 billion federal penalty

For a decade, the Justice Department delayed a winning criminal case against Endo Health Solutions. That allowed the Malvern company to expand its narcotics empire and execute a corporate escape plan.

A high school student uses a vaping device near a school campus in Cambridge, Mass., in 2018.

Nation & World

Supreme Court doesn’t seem convinced FDA was unfair in blocking flavored vapes teen use increased

Pennsylvania Attorney General Michelle A. Henry last month.

Health & Pharma

Pa., N.J. join settlement with generic drug firms accused of price-fixing. Consumers may be eligible for refunds.

Dennis Williams (left), Senior Vice President, Late Stage Development and Mark Stielow (right), Vice President U.S. Manufacturing and Technical Operations at Adaptimmune in the Navy Shipyard, Thursday, Sept. 12, 2024. After getting approval for a new type of cancer therapy (Tecelra) that uses the immune system to target cancer cells, the company is gearing up for patient orders to arrive.

Health

A Navy Yard biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients.

Health & Pharma

Endo’s end around: How a huge Philadelphia-based opioid maker escaped a $7 billion federal penalty

Supreme Court doesn’t seem convinced FDA was unfair in blocking flavored vapes teen use increased

Pa., N.J. join settlement with generic drug firms accused of price-fixing. Consumers may be eligible for refunds.

A Navy Yard biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients.

High insulin prices spur a federal lawsuit against three pharmacy benefit managers